In API Battle, China Chips Away At India’s Share; India Calls For Policy Safeguards
This article was originally published in PharmAsia News
China is becoming a serious threat to India’s indigenous API manufacturers, as India seeks policy safeguards such as anti-dumping duties and stricter inspections on Chinese imports.
You may also be interested in...
HYDERABAD - Indian companies are more entrepreneurially driven than their Chinese counterparts, and although a noticeable switch in mindset toward innovation is welcomed, the government needs to participate more in building infrastructure to raise confidence levels for global companies to funnel more research work to India, multinational companies urged
MUMBAI/TOKYO - Introduction of non-discriminatory or national treatment clauses for Indian generic companies in the latest trade agreement between India and Japan will facilitate wider access for Indian generic firms to the world's second-largest pharma market, but analysts predict headwinds await before companies get a real bang for their buck
Competition To Cooperation: Indian And Chinese Firms Agree On Draft MOU For Partnerships, Investments And GMP Training
MUMBAI - Intense price competition in key developed markets and common concerns for quality products and GMP issues is set to bring India and China together to boost collaborative efforts